MedPath

Cancer vaccine in combination with down-modulation of regulatory T cells for patients with incurable cancer

Not Applicable
Conditions
on-small cell lung cancer, Gastric cancer, Esophageal cancer, Colon cancer, Pancreatic cancer, Breast cancer
Registration Number
JPRN-UMIN000003613
Lead Sponsor
Department of Clinical Oncology, Kawasaki Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Autoimmune disease Uncontrollable complication infection, diabetes, hypertension, ischemic heart disease, cerebral infarction Pregnancy Allergy Interstitial lung disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath